http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-067788-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dded61bd89f99900518597c0958b9a9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-36 |
| filingDate | 2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-067788-A1 |
| titleOfInvention | PROCESS FOR THE PREPARATION OF A POLYPEPTIDE FOR PHARMACEUTICAL USE |
| abstract | A process for the preparation of a polypeptide from the amino acids L-alanine, L-glutamic acid, L-lysine, and L-tyrosine which comprises using the N-thiocarboxyanhydride of at least one amino acid as a starting material. Claim 13: A polypeptide or salt thereof acceptable for pharmaceutical use, characterized in that it comprises L-alanine, L-tyrosine, L-glutamate, and L-lysine, which is prepared according to a process comprising the steps of: a) polymerize L-alanine, optionally protected L-tyrosine, protected L-glutamate, and protected L-lysine to obtain a protected polypeptide; and b) deprotecting the protected polypeptide to obtain the polypeptide or salt thereof acceptable for pharmaceutical use; wherein at least one of L-alanine, optionally protected L-tyrosine, protected L-glutamate, and protected L-lysine is an N-thiocarboxyanhydride as shown in formula 1, R represents the side chain of L-alanine, L -optionally protected tyrosine, protected L-glutamate, and protected L-lysine. |
| priorityDate | 2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.